logo
[breadcrumb_custom]

Tag: Intellia Therapeutics Inc. (NASDAQ:NTLA)

ELVT Stock
News

Intellia Therapeutics Inc (NTLA Stock: A Sea of Opportunity

Intellia Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $47.48 on 06/14/23, and the lowest price during the same period was recorded at $22.67 on 11/13/23. 52-week price history of NTLA Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Intellia Therapeutics Inc’s current trading price is -34.67% away from its 52-week high, while its distance from the 52-week low is 36.86%. The stock’s price range during this period has fluctuated between $22.67 and $47.48. Shares of the company,

Stock

Intellia Therapeutics Inc’s Mixed Bag: Down -32.04% in 6 Months, Down -4.41% in 30 Days

Intellia Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $47.48 on 06/14/23, while the lowest price during the same period was $22.67 on 11/13/23. 52-week price history of NTLA Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Intellia Therapeutics Inc’s current trading price is -44.29% away from its 52-week high, while its distance from the 52-week low is 16.70%. The stock’s price range for

Stock

The Significance of Moving Averages in Intellia Therapeutics Inc Inc. (NTLA) Price Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -17.32% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -40.44%. Over the past 30 days, the price of NTLA has leaped by -20.65%. And in the last five days, it has fallen by -2.25%. Intellia Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price